MedTrace Logo

Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers

NCT01689116 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 179

Last updated 2025-05-29

No results posted yet for this study

Summary

This is a single-center, multiple-dose, randomized, double-blind, double-dummy, placebo-controlled, active-comparator, parallel study in healthy volunteers.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Bardoxolone Methyl 20mg

Oral

DRUG

Bardoxolone Methyl 80mg

Oral

DRUG

Bardoxolone Methyl Placebo

Oral

DRUG

Moxifloxacin 400mg

Oral

DRUG

Moxifloxacin Placebo

Oral

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01689116 on ClinicalTrials.gov